Search

everythinglearnresearchcommunity

for

Search:↓

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

Platelet-rich plasma treatment is effective for hair loss in patients regardless of their thyroid antibody levels.

BSSP may help skin tumors grow and could be a marker or target for skin cancer treatment.

Squaric acid dibutylester for alopecia areata can cause benign skin lymphoid growths.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

DNA virus-induced tumors have consistent isozyme profiles, unlike other tumor types.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Early recognition and treatment of SLE can improve outcomes in patients with complex symptoms.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Cytokeratin 19 and cytokeratin 15 are key markers for monitoring the quality and self-renewing potential of engineered skin.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

Alopecia areata may be caused by antibodies targeting specific hair follicle proteins, hindering hair growth.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

A woman with lupus had blood cell destruction, treated successfully with medication.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

The document tests knowledge and decision-making in hematology through multiple-choice questions.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

An 87-year-old woman was diagnosed with type 3 autoimmune polyendocrine syndrome and had multiple autoimmune issues.

Mogamulizumab can cause hair loss and skin rashes.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Squaric acid dibutylester effectively treats alopecia areata.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Belatacept may be a promising treatment for alopecia areata.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.